IgG-Switched cll has a distinct immunogenetic signature from the common md variant: Ontogenetic implications

Clinical Cancer Research

Volumn 20, Issue 2, 2014, Pages 323-330

  Vardi, Anna ^a   Agathangelidis, Andreas ^c   Sutton, Lesley Ann ^d   Chatzouli, Maria ^e   Scarfòo, Lydia ^c   Mansouri, Larry ^d   Douka, Vassiliki ^a   Anagnostopoulos, Achilles ^a   Darzentas, Nikos ^b,f   Rosenquist, Richard ^d   Ghia, Paolo ^c   Belessi, Chrysoula ^e   Stamatopoulos, Kostas ^a,b,d  

^a G PAPANICOLAOU HOSPITAL   (Greece)

^b INFORMATION TECHNOLOGIES INSTITUTE   (Greece)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d UPPSALA UNIVERSITY   (Sweden)

^e GENERAL HOSPITAL OF NIKEA   (Greece)

^f MASARYK UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN MU CHAIN;

AGED; ARTICLE; BIOINFORMATICS; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOGENETICS; IMMUNOGLOBULIN G SWITCHED CHRONIC LYMPHOCYTIC LEUKEMIA; IMMUNOGLOBULIN HEAVY CHAIN GENE; MAJOR CLINICAL STUDY; MALE; MU AND DELTA ISOTYPE CHRONIC LYMPHOCYTIC LEUKEMIA; PRIORITY JOURNAL; SOMATIC HYPERMUTATION; STEREOTYPY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE REARRANGEMENT, B-LYMPHOCYTE; HUMANS; IMMUNOGENETICS; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN M; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, B-CELL; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN;

EID: 84892762207     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-13-1993     Document Type: Article

References (39)

1. Katayama Y, Sakai A, Katsutani S, Takimoto Y, Kimura A. Lack of allelic exclusion and isotype switching in B cell chronic lymphocytic leukemia. Am J Hematol 2001;68:295-7
2. Cerutti A, Zan H, Kim EC, Shah S, Schattner EJ, Schaffer A, et al. Ongoing in vivo immunoglobulin class switch DNA recombination in chronic lymphocytic leukemia B cells. J Immunol 2002;169:6594-603
3. Oppezzo P, Magnac C, Bianchi S, Vuillier F, Tiscornia A,Dumas G, et al. Do CLL B cells correspond to naive or memory B-lymphocytes? Evidence for an active Ig switch unrelated to phenotype expression and Ig mutational pattern in B-CLL cells. Leukemia 2002;16:2438-46
4. Efremov DG, Ivanovski M, Batista FD, Pozzato G, Burrone OR. IgMproducing chronic lymphocytic leukemia cells undergo immunoglobulin isotype-switching without acquiring somatic mutations. J Clin Invest 1996;98:290-8
5. Oppezzo P, Vuillier F, Vasconcelos Y, Dumas G, Magnac C, Payelle- Brogard B, et al. Chronic lymphocytic leukemia B cells expressing AID display dissociation between class switch recombination and somatic hypermutation. Blood 2003;101:4029-32
6. Patten PE, ChuCC, Albesiano E, Damle RN, Yan XJ, Kim D, et al. IGHVunmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions. Blood 2012;120:4802-11
7. Palacios F, Moreno P, Morande P, Abreu C, Correa A, Porro V, et al. High expression of AID and active class switch recombination might account for a more aggressive disease in unmutated CLL patients: link with an activated microenvironment in CLL disease. Blood 2010;115: 4488-96
8. Geisler CH, Larsen JK, Hansen NE, Hansen MM, Christensen BE, Lund B, et al. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood 1991;78:1795-802
9. Potter KN, Mockridge CI, Neville L, Wheatley I, Schenk M, Orchard J, et al. Structural and functional features of the B-cell receptor in IgGpositive chronic lymphocytic leukemia. Clin Cancer Res 2006;12: 1672-9
10. Lanham S, Hamblin T, Oscier D, Ibbotson R, Stevenson F, Packham G. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia. Blood 2003;101:1087-93
11. Mockridge CI, Potter KN, Wheatley I, Neville LA, Packham G, Stevenson FK. Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status. Blood 2007; 109:4424-31
12. Muzio M, Apollonio B, Scielzo C, Frenquelli M, Vandoni I, Boussiotis V, et al. Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: A molecular signature of anergy. Blood 2008; 112:188-95
13. Efremov DG, Wiestner A, Laurenti L. Novel agents and emerging strategies for targeting the B-cell receptor pathway in CLL. Mediterr J Hematol Infect Dis 2012; 4:e2012067
14. Stevenson FK, Krysov S, Davies AJ, Steele AJ, Packham G. B-cell receptor signaling in chronic lymphocytic leukemia. Blood 2011;118: 4313-20
15. Wiestner A. Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia. Blood 2012;120:4684-91
16. Woyach JA, Johnson AJ, Byrd JC. The B-cell receptor signaling pathway as a therapeutic target in CLL. Blood 2012;120:1175-84
17. Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: A report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute- Working Group 1996 guidelines. Blood 2008;111:5446-56
18. Murray F, Darzentas N, Hadzidimitriou A, Tobin G, Boudjogra M, Scielzo C, et al. Stereotyped patterns of somatic hypermutation in subsets of patientswith chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood 2008;111: 1524-33
19. Darzentas N, Hadzidimitriou A, Murray F, Hatzi K, Josefsson P, Laoutaris N, et al. A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence. Leukemia 2010;24:125-32
20. Agathangelidis A, Darzentas N, Hadzidimitriou A, Brochet X, Murray F, Yan XJ, et al. Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: A molecular classification with implications for targeted therapies. Blood 2012;119:4467-75
21. Widhopf GF II, Rassenti LZ, Toy TL, Gribben JG, Wierda WG, Kipps TJ. Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood 2004;104: 2499-504
22. Forconi F, Potter KN, Wheatley I, Darzentas N, Sozzi E, Stamatopoulos K, et al. The normal IGHV1-69-derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL. Blood 2010; 115:71-7
23. Barbas SM, Ditzel HJ, Salonen EM, Yang WP, Silverman GJ, Burton DR. Human autoantibody recognition of DNA. Proc Natl Acad SciUSA 1995;92:2529-33
24. Athanasiadou A, Stamatopoulos K, Gaitatzi M, Stavroyianni N, Fassas A, Anagnostopoulos A. Recurrent cytogenetic findings in subsets of patients with chronic lymphocytic leukemia expressing IgG-switched stereotyped immunoglobulins. Haematologica 2008;93:473-4
25. Baliakas P, Minga E, Hadzidimitriou A, Tsanousa A, Sutton LA, Scarfo L, et al. CLL: different ages, different antigen receptor profiles. Haematologica 2013;98:34-5
26. Stamatopoulos K, Belessi C, Moreno C, Boudjograh M, Guida G, Smilevska T, et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood 2007;109:259-70
27. Potter KN, Hobby P, Klijn S, Stevenson FK, Sutton BJ. Evidence for involvement of a hydrophobic patch in framework region 1 of human V4-34-encoded Igs in recognition of the red blood cell I antigen. J Immunol 2002;169:3777-82
28. Hadzidimitriou A, Darzentas N, Murray F, Smilevska T, Arvaniti E, Tresoldi C, et al. Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia. Blood 2009;113:403-11
29. Sutton LA, Kostareli E, Hadzidimitriou A, Darzentas N, Tsaftaris A, Anagnostopoulos A, et al. Extensive intraclonal diversification in a subgroup of chronic lymphocytic leukemia patients with stereotyped IGHV4-34 receptors: implications for ongoing interactions with antigen. Blood 2009;114:4460-8
30. Kostareli E, Sutton LA, Hadzidimitriou A, Darzentas N, Kouvatsi A, Tsaftaris A, et al. Intraclonal diversification of immunoglobulin light chains in a subset of chronic lymphocytic leukemia alludes to antigendriven clonal evolution. Leukemia 2010;24:1317-24
31. Sutton LA, Kostareli E, Stalika E, Tsaftaris A, Anagnostopoulos A, Darzentas N, et al. Temporal dynamics of clonal evolution in chronic lymphocytic leukemia with stereotyped IGHV4-34/IGKV2-30 antigen receptors: longitudinal immunogenetic evidence. Mol Med 2013;19: 230-6
32. Catera R, Magli AR, Kolitz JE, Allen SL, Rai KR, Chu CC, et al. Somatic hypermutation in stereotyped subset 4 BCRs/mAbs of CLL patients, expressing IGHV4-34 gene, edits anti-DNA reactivity. Blood 2010; 116:2444
33. DeKosky BJ, Ippolito GC, Deschner RP, Lavinder JJ, Wine Y, Rawlings BM, et al. High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire. Nat Biotechnol 2013; 31:166-9
34. Gounari M, Ntoufa S, Chu CC, Tsaftaris A, Chiorazzi N, Stamatopoulos K, et al. Promiscuous antigen reactivity may underlie clinical aggressiveness and increased risk for Richter's syndrome in chronic lymphocytic leukemia with stereotyped IGHV4-39/IGKV1(D)-39 B cell receptors. Blood 2012;120:561
35. Taylor JJ, Pape KA, Jenkins MK. A germinal center-independent pathway generates unswitched memory B cells early in the primary response. J Exp Med 2012;209:597-606
36. Kaji T, Ishige A, Hikida M, Taka J, Hijikata A, Kubo M, et al. Distinct cellular pathways select germline-encoded and somatically mutated antibodies into immunological memory. J Exp Med 2012;209: 2079-97
37. Chappell CP, Draves KE, Giltiay NV, Clark EA. Extrafollicular B cell activation by marginal zone dendritic cells drives T cell-dependent antibody responses. J Exp Med 2012;209:1825-40
38. Phan TG, Amesbury M, Gardam S, Crosbie J, Hasbold J, Hodgkin PD, et al. B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells. J Exp Med 2003;197: 845-60
39. Ntoufa S, Vardi A, Papakonstantinou N, Anagnostopoulos A, Aleporou- Marinou V, Belessi C, et al. Distinct innate immunity pathways to activation and tolerance in subgroups of chronic lymphocytic leukemia with distinct immunoglobulin receptors. Mol Med 2012;18: 1281-91